Mesothelioma Cancer Centers
University of Arizona Cancer Center
Doctors Affiliated with this Treatment Facility
The University of Arizona Cancer Center was founded in 1976 as part of the university's medical school, which had opened its doors nine years earlier. In 1990, the center received federal recognition as a comprehensive cancer center by the National Cancer Institute, a division of the National Institutes of Health. It is the only National Cancer Institute-designated Comprehensive Cancer Center located in the state of Arizona.
Today, the University of Arizona Cancer Center works to fight cancer in six scientific research areas: cancer biology, cancer imaging, cancer prevention and control, gastrointestinal cancer, therapeutic development and biobehavioral and social sciences research. Researchers in these six areas collaborate with physicians to provide a “benchtop to bedside” approach, developing new technologies and working to quickly translate them into patient care. In fact, the cancer center’s research portfolio includes more than $70 million in annual research funding, including millions in funding from the federal government’s National Cancer Institute.
The University of Arizona Cancer Center has an internationally-renowned cancer team helping lead research, including for mesothelioma, and cutting-edge treatments for patients. Hundreds of doctors, scientists and medical students from the affiliated University of Arizona College of Medicine work together in over 70 different research labs at the center in an effort to find better cancer prevention methods, diagnostic tools and a cure for cancer. Much of the center's research portfolio includes more than $70 million in annual research funding, including millions in funding from the federal government's National Cancer Institute.
In addition to their robust research programs, the center is recognized as being on the cutting edge of cancer treatment. With a multidisciplinary approach, medical, hematological, radiation and surgical oncologists come together with nurses, pharmacists and others to create a personalized care plan for each individual. While the center offers a variety of standard mesothelioma cancer treatments, they have a specialized radiation oncology department with state-of-the-art equipment to offer the latest radiation therapies. Mesothelioma patients may benefit from external beam therapy, brachytherapy, IMRT and more. The center also offers respiratory gating, which allows them to determine how much a tumor moves while a patient is breathing, thus allowing for more targeted radiation treatments with less side effects.
The University of Arizona Cancer Center also offers various support services and areas to help keep mesothelioma patients comfortable during their stay and beyond including meditation gardens, massage and touch therapy, classes to better educate patients on their treatment options. They also offer a Survivorship Program at their Dignity Health St. Joseph's Hospital and Medical Center location. This program caters to patients at all stages of their diagnosis, whether living with cancer, in remission or free of cancer. Patients can find emotional or spiritual help as well as physical help to deal with treatment side effects.
- Radiation oncology
- Gene therapy
- Pleural mesothelioma
- Sarcomatoid mesothelioma
- National Cancer Institute (NCI) Comprehensive Cancer Center Designation
- U.S. News & World Report Best Hospital
Mesothelioma Clinical Trials at University of Arizona Cancer Center
The following clinical trials are in progress or actively recruiting participants at University of Arizona Cancer Center:
Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors
Conditions: Metastatic Cancer; Solid Tumors; Colorectal Cancer (CRC); Gastric Cancer; Head and Neck Cancer; Lung Cancer; Renal Cell Carcinoma (RCC); Bladder Cancer; UC (Urothelial Cancer); Mesothelioma Last Updated: July 11, 2019 Status: Recruiting
Author: Linda Molinari
Editor in Chief, Mesothelioma Cancer AllianceRead about Linda
Reviewer: Annette Charlevois
Patient Support CoordinatorRead about Annette